Monkeypox: From Zoonotic Disease to Global Health Crises
Year: 2024
Type: article
Abstract: The emergence of the 2022 multi-country monkeypox outbreak has presented a significant public health challenge, compounding the ongoing coronavirus disease 2019 (COVID-19) pandemic. The disease has rapidly spread across six continents, affecting 104 countries worldwide, with the highest incidence observed in North America and Europe. The etiologic agent, monkeypox virus (MPXV), was first identified in 1959 following isolation from infected monkeys. While human-to-human transmission has been documented since the 1970s, primarily in endemic regions of West and Central Africa, the recent outbreak has exhibited unprecedented rates of transmission, raising concerns about its potential for community spread in non-endemic areas. To mitigate the impact of this re-emerging viral disease, healthcare workers, public health policymakers, and the general public must possess a thorough understanding of its epidemiology, etiology, pathogenesis, clinical manifestations, diagnosis, and management.
Author: Tejas Bagmar, Bhagyashri Randhwan, Naman Gandhi, Harish Changediya, Pruthviraj Awate, Sanket Walekar, Tanvi Bafana, Sayali Gandhi
Language: English
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6968248148
FWCI:
Cites:
Cited by:
Related to: